PEAR

Pear Therapeutics, Inc. Class A Common Stock

Delisted

PEAR was delisted on the 18th of April, 2023.

72 hedge funds and large institutions have $203M invested in Pear Therapeutics, Inc. Class A Common Stock in 2021 Q2 according to their latest regulatory filings, with 55 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
72
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$13.9M
2 +$12.9M
3 +$11.9M
4
Nomura Holdings
Nomura Holdings
Japan
+$11.6M
5
Citadel Advisors
Citadel Advisors
Florida
+$9.89M

Top Sellers

1 -$13.5K
2 -$1K
Name Holding Trade Value Shares
Change
Change in
Stake
51
$494K
52
$484K
53
$460K
54
$427K
55
$395K
56
$362K
57
$247K
58
$247K
59
$247K
60
$247K
61
$246K
62
$239K
63
$198K
64
$148K
65
$123K
66
$99K
67
$99K
68
$56K
69
$7K
70
$4.94K
71
$1K
72
$673
73